HRC Breast cancer study

Cancer treatment can be expensive. It is important that any treatment offered is effective and used efficiently. Much of the evidence base for treatment has a potential for bias in favour of treatment. Our research will allow objective evaluation of outcomes in relation to different treatment modalities in a real life setting (as opposed to relying on extrapolation of findings from clinical trials). We will not only be able to give clinicians better advice on treatment options, we will be able to advise on where management systems could be improved to ensure more effective treatments are equitably applied. Whilst we have not proposed a full economic evaluation of different treatment options we will be able to produce relevant decision trees that could be used to inform decision making on the most efficient treatment pathways